EP
LUNG icon

Essential Partners’s Pulmonx LUNG Stock Holding History

Essential Partners’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22K Buy
937
+679
+263% +$935 ﹤0.01% 2156
2026
Q1 		$333 Buy
258
+240
+1,333% +$397 ﹤0.01% 2535
2025
Q4 		$40 Buy
18
+2
+13% +$4 ﹤0.01% 2657
2025
Q3 		$26 Buy
+16
New +$33 ﹤0.01% 2620

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Essential Partners's LUNG Position: Q2 2026 in Review

Essential Partners increased its Pulmonx (LUNG) stake by 263% in Q2 2026, buying an estimated $935 and bringing the position to 937 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

Essential Partners first reported a position in LUNG in Q3 2025 and has held it in 4 quarters since. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Essential Partners held 937 shares of Pulmonx worth $1.22K as of Q2 2026.
  • Essential Partners bought 679 Pulmonx shares in Q2 2026, an estimated $935.
  • Pulmonx made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2156 holding.
  • Essential Partners first reported a position in Pulmonx in Q3 2025 and has held it in 4 quarters since.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.